Arcturus Therapeutics Holdings (ARCT)
(Real Time Quote from BATS)
$25.51 USD
+0.26 (1.03%)
Updated Oct 2, 2024 10:47 AM ET
1-Strong Buy of 5 1
D Value A Growth C Momentum C VGM
Detailed Estimates
EPS Estimates
Exp Earnings Date | 11/12/24 |
---|---|
Current Quarter | -0.70 |
EPS Last Quarter | -0.64 |
Last EPS Surprise | 65.41% |
ABR | 1.00 |
Earnings ESP
|
0.00% |
---|---|
Current Year | -2.60 |
Next Year | 0.21 |
EPS (TTM) | -2.57 |
P/E (F1) | NA |
Sales Estimates
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | 49.16M | 81.28M | 218.29M | 322.88M |
# of Estimates | 4 | 4 | 4 | 4 |
High Estimate | 65.00M | 109.48M | 241.35M | 509.95M |
Low Estimate | 30.00M | 60.53M | 206.06M | 250.32M |
Year ago Sales | 45.14M | 33.99M | 169.93M | 218.29M |
Year over Year Growth Est. | 8.91% | 139.11% | 28.46% | 47.91% |
Earnings Estimates
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | -0.70 | 0.28 | -2.60 | 0.21 |
# of Estimates | 4 | 4 | 5 | 4 |
Most Recent Consensus | -0.38 | -0.43 | -2.45 | -1.74 |
High Estimate | -0.15 | 1.24 | -1.34 | 4.68 |
Low Estimate | -1.29 | -0.43 | -4.81 | -1.74 |
Year ago EPS | -0.61 | -0.32 | -1.99 | -2.60 |
Year over Year Growth Est. | -14.75% | 187.50% | -30.65% | 107.96% |
Agreement - Estimate Revisions
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 0 | 0 | 0 | 0 |
Up Last 30 Days | 0 | 0 | 0 | 0 |
Up Last 60 Days | 2 | 3 | 4 | 3 |
Down Last 7 Days | 0 | 0 | 0 | 0 |
Down Last 30 Days | 0 | 0 | 0 | 0 |
Down Last 60 Days | 1 | 0 | 0 | 0 |
Magnitude - Consensus Estimate Trend
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Current | -0.70 | 0.28 | -2.60 | 0.21 |
7 Days Ago | -0.70 | 0.28 | -2.60 | 0.21 |
30 Days Ago | -0.70 | 0.28 | -2.60 | 0.21 |
60 Days Ago | -0.90 | -0.34 | -4.39 | -0.45 |
90 Days Ago | -0.90 | -0.34 | -4.39 | -0.45 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | -0.70 | 0.28 | -2.60 | 0.21 |
Zacks Consensus Estimate | -0.70 | 0.28 | -2.60 | 0.21 |
Earnings ESP | 0.00% | 0.00% | 0.00% | 0.00% |
Surprise - Reported Earnings History
Quarter Ending (6/2024) |
Quarter Ending (3/2024) |
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | -0.64 | -1.00 | -0.32 | -0.61 | NA |
Estimate | -1.85 | -1.17 | -1.69 | -1.79 | NA |
Difference | 1.21 | 0.17 | 1.37 | 1.18 | 0.98 |
Surprise | 65.41% | 14.53% | 81.07% | 65.92% | 56.73% |
Quarterly Estimates By Analyst
Zacks Premium Subscription Required Learn more
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more